Find Acecainide manufacturers, exporters & distributors on PharmaCompass

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 34118-92-8, N-acetylprocainamide hydrochloride, Acecainide hcl, Napa, Asl 601, Asl-601

Molecular Formula

C₁₅H₂₄ClN₃O₂

Molecular Weight

313.82 g/mol

InChI Key

IYEWBJUCJHKLHD-UHFFFAOYSA-N

FDA UNII

B9K738KX14

A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.

1 2D Structure

Acecainide

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

4-acetamido-N-[2-(diethylamino)ethyl]benzamide;hydrochloride

2.1.2 InChI

InChI=1S/C15H23N3O2.ClH/c1-4-18(5-2)11-10-16-15(20)13-6-8-14(9-7-13)17-12(3)19;/h6-9H,4-5,10-11H2,1-3H3,(H,16,20)(H,17,19);1H

2.1.3 InChI Key

IYEWBJUCJHKLHD-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCN(CC)CCNC(=O)C1=CC=C(C=C1)NC(=O)C.Cl

2.2 Other Identifiers

2.2.1 UNII

B9K738KX14

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Acecainide

2. Acecainide Monohydrochloride

3. Acetylprocainamide

4. Hydrochloride, Acecainide

5. Monohydrochloride, Acecainide

6. N Acetylprocainamide

7. N-acetylprocainamide

2.3.2 Depositor-Supplied Synonyms

1. 34118-92-8

2. N-acetylprocainamide Hydrochloride

3. Acecainide Hcl

4. Napa

5. Asl 601

6. Asl-601

7. 4-acetamido-n-(2-(diethylamino)ethyl)benzamide Hydrochloride

8. Acecainide Hydrochloride [usan]

9. Nsc-759312

10. 4'-((2-(diethylamino)ethyl)carbamoyl)acetanilide Monohydrochloride

11. 34118-92-8 (hcl)

12. Mls000863278

13. Asl601;acecainide Hydrochloride

14. B9k738kx14

15. N-acetylprocainamide (hydrochloride)

16. Ncgc00093534-02

17. Dsstox_cid_25748

18. Dsstox_rid_81092

19. Dsstox_gsid_45748

20. Acecainide Hydrochloride (usan)

21. Benzamide, 4-(acetylamino)-n-(2-(diethylamino)ethyl)-, Monohydrochloride

22. Smr000059132

23. Cas-34118-92-8

24. Unii-b9k738kx14

25. Sr-01000000030

26. Einecs 251-831-2

27. Opera_id_64

28. Asl 601(acecainide)

29. Mls000028843

30. Mls001148141

31. Schembl122991

32. Spectrum2300154

33. Chembl1256805

34. Dtxsid1045748

35. Pharmakon1600-02300154

36. Bcp20733

37. Tox21_111206

38. Tox21_500009

39. Acecainide Hydrochloride [mi]

40. Nsc759312

41. Akos015888341

42. Tox21_111206_1

43. Ccg-213649

44. Lp00009

45. Nsc 759312

46. Acecainide Hydrochloride [mart.]

47. N-acetylprocainamide Hydrochloride, 99%

48. Ncgc00015072-10

49. Ncgc00093534-01

50. Ncgc00093534-03

51. Ncgc00260694-01

52. As-75674

53. Db-048569

54. Eu-0100009

55. Ft-0639157

56. A 5909

57. A20512

58. D02746

59. N16908

60. 4-acetamido-n-(2-(diethylamino)ethyl)benzamide Hcl

61. J-019456

62. Sr-01000000030-2

63. Acedainide; N-acetylnovocainamide Hydrochloride; Napa

64. Q27274550

65. 4-acetamido-n-(2-(diethylamino)ethyl)benzamidehydrochloride

66. N-acetylprocainamide Hydrochloride, >=99% (hplc), Powder

67. 4-acetamido-n-[2-(diethylamino)ethyl]benzamide;hydrochloride

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₁₅H₂₄ClN₃O₂
Molecular Weight	313.82 g/mol
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	7
Exact Mass	313.1557047 g/mol
Monoisotopic Mass	313.1557047 g/mol
Topological Polar Surface Area	61.4 Å²
Heavy Atom Count	21
Formal Charge	0
Complexity	308
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)

API SUPPLIERS